CClinicalTrials.gg
CompletedNCT01430325TOP-DIVERUpdated Feb 15, 2013Results posted

Test of Chamber Pressure to Divers and Chamber Attendants

An interventional study of Hyperbaric Oxygen (1.5 atm abs) and Sham Chamber Session in Traumatic Brain Injury, sponsored by Intermountain Health Care, Inc.. Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-02-15.

Sponsored by Intermountain Health Care, Inc. · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

SCUBA divers and chamber inside attendants will undergo a brief hyperbaric chamber excursion and will be asked to what chamber pressure they were compressed and what gas they breathed.

Read the detailed description

In clinical trials evaluating hyperbaric oxygen, blinding can be challenging. Options for participant blinding include offering regular air at a lower pressure than the hyperbaric oxygen intervention, or compressing all participants to the same pressure but providing different gas mixes to the active and sham arms.

In some trials of hyperbaric oxygen for brain injury, investigators offer a sham chamber session (regular air at 1.2 atmospheres absolute [atm abs]) compared to the active intervention, hyperbaric oxygen (100% oxygen at 1.5 atm abs). It is unknown whether individuals familiar with pressure changes, such as divers and hyperbaric chamber inside attendants, could discern the difference between these pressures and thereby become unblinded to study allocation.

In this study, 80 experienced divers and chamber inside attendants will be enrolled and randomly assigned to one of four possible chamber pressures and one of two breathing gases. After a brief hyperbaric chamber excursion, they will be asked to what chamber pressure they were compressed and what gas they breathed. If participants can accurately report chamber pressure or breathing gas, pressure-familiar individuals should be excluded from blinded clinical trials of hyperbaric oxygen.

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • Hyperbaric oxygen
03

In context

Brain Injuries

2,112 studies on the registry are indexed under Brain Injuries; 384 are open to participants now.

This study's enrollment of 42 is below the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Intermountain Health Care, Inc. is the lead sponsor of 118 studies on the registry; 15 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 3 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adult, age 18 - 65 years
  • Completion of medical history questionnaire without concerns identified for exposure to increased pressure
  • Familiarity with atmospheric pressure change:
  • Experienced and active hyperbaric chamber inside attendant: more than 50 hyperbaric compressions, with more than 4 have been in the last 4 months; or
  • Experienced and active SCUBA diver: more than 20 lifetime compressed gas open water (not swimming pool) dives, with more than 10 in the last 12 months
  • Able to equalize middle ear pressure easily

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Known risk for barotrauma, as identified on the medical history questionnaire, such as:
  • Recent (within 12 months) inner ear or sinus surgery
  • Spontaneous pneumothorax
  • Pulmonary cysts
  • Emphysema
  • Bullous lung disease
  • Chronic obstructive pulmonary disease needing chronic active therapy
  • Inability to tolerate chamber confinement or pressure
  • Presence of heart failure
  • Presence of any implanted electrical device, except hyperbaric-approved pacemakers
  • Presence of middle-ear tympanostomy tubes
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Single group
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
42 participants (actual)

Study arms

  • Sham comparator
    Sea Level Equivalent 1.2 atm abs (air)

    Sham Chamber Session Sea Level Equivalent 1.2 atm abs (2.6 psig) breathing regular air 20-chamber excursion

    Drug: Sham Chamber Session

  • Experimental
    Sea Level Equivalent 1.5 atm abs (O2)

    Hyperbaric Oxygen (1.5 atm abs) Sea Level Equivalent 1.5 atm abs (6.2 psig) breathing 100% oxygen 20-minute chamber excursion

    Drug: Hyperbaric Oxygen (1.5 atm abs)

  • Sham comparator
    Altitude Equivalent 1.2 atm abs (air)

    Sham Chamber Session Altitude Equivalent 1.2 atm abs (5.1 psig) breathing regular air 20-minute chamber excursion

    Drug: Sham Chamber Session

  • Experimental
    Altitude Equivalent 1.5 atm abs (O2)

    Hyperbaric Oxygen (1.5 atm abs) Altitude Equivalent 1.5 atm abs (9.6 psig) breathing 100% oxygen 20-minute chamber excursion

    Drug: Hyperbaric Oxygen (1.5 atm abs)

Interventions

  • DrugHyperbaric Oxygen (1.5 atm abs)

    Hyperbaric oxygen (100% oxygen) delivered at a chamber pressure of 1.5 atm abs.

    Also known as: HBO2, HBO, HBOT

  • DrugSham Chamber Session

    Sham control chamber session: regular air delivered at a chamber pressure of 1.2 atm abs

    Also known as: Sham control, Air pressurization

06

What researchers measure

Primary outcomes

  1. Participants Indicating "I do Not Know" on Depth Questionnaire.

    Participants indicating "I do not know" on depth questionnaire instead of providing a free response guess.

    Time frame: Within 15 minutes of chamber excursion

  2. Participant Perception of Depth

    Mean depth perception for participants providing a free response.

    Time frame: Within 15 minutes of chamber excursion

  3. Participant Perception of Breathing Gas

    Percent of participants in each arm guessing that their breathing gas was 100% oxygen.

    Time frame: Within 15 minutes of chamber excursion

07

Results

Posted Feb 7, 2013
Limitations and caveats
Smaller sample size; enrollment was stopped at 42 participants when investigators had exhausted the planned recruitment methods. Very few inside attendants enrolled. Pressures in this study were relatively close.

Participant flow

82 individuals responded to study announcements and were pre-screened by telephone, of which 25 were deemed ineligible (due to inadequate diving experience). An additional 15 individuals declined to participate (primarily due to scheduling conflicts). 42 divers and chamber inside attendants signed informed consent and participated in the study.

Participant flow — Overall Study
MilestoneAltitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)
Started1012812
Completed1012812
Not completed0000

Outcome measures

PrimaryParticipants Indicating "I do Not Know" on Depth Questionnaire.

Participants indicating "I do not know" on depth questionnaire instead of providing a free response guess.

Time frame:
Within 15 minutes of chamber excursion
Reported as:
Number · participants
Participants Indicating "I do Not Know" on Depth Questionnaire.
participantsAltitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)
Participants Indicating "I do Not Know" on Depth Questionnaire.7444
PrimaryParticipant Perception of Depth

Mean depth perception for participants providing a free response.

Time frame:
Within 15 minutes of chamber excursion
Reported as:
Mean · fsw
Participant Perception of Depth
fswAltitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)
Participant Perception of Depth65 ± 1335 ± 1623 ± 1223 ± 14
PrimaryParticipant Perception of Breathing Gas

Percent of participants in each arm guessing that their breathing gas was 100% oxygen.

Time frame:
Within 15 minutes of chamber excursion
Reported as:
Number · percentage of participants
Participant Perception of Breathing Gas
percentage of participantsAltitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)
Participant Perception of Breathing Gas80918867

Adverse events

Collected over Adverse events were collected from the time that participants signed consent until they departed after the chamber excursion (approximately 1 hour).. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Altitude Equivalent 1.2 Atm Abs (Air)—0/10 (0%)1/10 (10%)
Altitude Equivalent 1.5 Atm Abs (O2)—0/12 (0%)0/12 (0%)
Sea Level Equivalent 1.2 Atm Abs (Air)—0/8 (0%)0/8 (0%)
Sea Level Equivalent 1.5 Atm Abs (O2)—0/12 (0%)0/12 (0%)
Most frequent other events
Most frequent other events
EventAltitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)
HeadacheNervous system disorders1/100/120/80/12

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Altitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)Total
<=18 years00000
Between 18 and 65 years101281242
>=65 years00000
Age Continuous
Age Continuous(years)Altitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)Total
Mean45 ± 1049 ± 7.847 ± 9.345 ± 1346 ± 10
Sex: Female, Male
Sex: Female, Male(Participants)Altitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)Total
Female321410
Male7107832
Region of Enrollment
Region of Enrollment(participants)Altitude Equivalent 1.2 Atm Abs (Air)Altitude Equivalent 1.5 Atm Abs (O2)Sea Level Equivalent 1.2 Atm Abs (Air)Sea Level Equivalent 1.5 Atm Abs (O2)Total
United States101281242
08

Study locations

2 sites
  • Intermountain Medical Center
    Murray, Utah 84107, United States
  • LDS Hospital
    Salt Lake City, Utah 84143, United States
09

References and documents

Publications

  • Clarke D. Effective patient blinding during hyperbaric trials. Undersea Hyperb Med. 2009 Jan-Feb;36(1):13-7. PubMed 19341123 ↗
  • Jansen T, Mortensen CR, Tvede MF. It is possible to perform a double-blind hyperbaric session: a double-blinded randomized trial performed on healthy volunteers. Undersea Hyperb Med. 2009 Sep-Oct;36(5):347-51. PubMed 20112525 ↗
  • Weaver LK, Hopkins RO, Churchill S, Haberstock D. Double-Blinding is Possible in Hyperbaric Oxygen (HBO2) Randomized Clinical Trials (RCT) Using a Minimal Chamber Pressurization as Control. Undersea Hyperb Med 1997;24(Suppl):36.
  • Weaver LK, Churchill SK, Bell J, Deru K, Snow GL. A blinded trial to investigate whether 'pressure-familiar' individuals can determine chamber pressure. Undersea Hyperb Med. 2012 Jul-Aug;39(4):801-5. PubMed 22908836 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01430325
Lead sponsor
Intermountain Health Care, Inc.
Responsible party
Sponsor
First posted
Sep 8, 2011
Start date
Jul 2011
Primary completion
Oct 2011
Completion
Oct 2011
Results posted
Feb 7, 2013
Last update
Feb 15, 2013

Study contacts

Lindell K. Weaver, MD
principal investigator · Intermountain Health Care, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion